Investigation of the ability of several naturally occurring and synthetic polyanions to bind to and potentiate the biological activity of acidic fibroblast growth factor
- 1 October 1993
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 157 (1), 184-189
- https://doi.org/10.1002/jcp.1041570124
Abstract
The ability of several animal, plant, and bacterial derived polyanions (PAs) as well as synthetic PAs to compete with heparin for the binding of acidic fibroblast growth factor (aFGF) was correlated with their ability to potentiate the mitogenic and neurotrophic actions of this factor. Dextran sulphate, K-carrageenan, pentosan sulphate, polyanethole sulfonate, heparin, and fucoidin competed for the heparin binding site on aFGF at relatively low concentrations (≤50 μg/ml). λ-carrageenan, ι-carrageenan, and polyvinyl sulphate exhibited lower affinity for aFGF, whereas hyaluronic acid, dermatan sulphate, chondroitin-6-sulphate, chondroitin-4-sulphate, and uncharged dextran displayed very low or no demonstrable affinity. Potentiation of the mitogenic action of aFGF for Balb/c 3T3 fibroblasts tended to be in general agreement with the aFGF binding affinity of the PAs. However, polyanethole sulfonate, the carrageenans, polyvinyl sulphate, fucoidin, and pentosan sulphate exerted a mitogenic action on the 3T3 cells that was independent of, and in addition to, the ability of these GAGs to potentiate the action of aFGF. The ability to potentiate the neurotrophic action of aFGF for E8 chick ciliary neurons was a general property of those PA with low or no activity in the mitogen assay. Thus hyaluronic acid, dermatan sulphate, chondroitin-4-sulphate, chondroitin-6-sulphate, and even uncharged dextran all potentiated aFGF induced neuronal survival. The differential effects of these PA in potentiating the biological activities of aFGF are discussed in relation to their ability to compete for the heparin-binding site of aFGF.Keywords
This publication has 35 references indexed in Scilit:
- Ability of different chemically modified heparins to potentiate the biological activity of heparin-binding growth factor 1. Lack of correlation with growth factor bindingBiochemistry, 1992
- Heparan Sulfate Proteoglycans of Ras-Transformed 3T3 or Neuroblastoma Cells.Annals of the New York Academy of Sciences, 1989
- Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half‐lifeJournal of Cellular Physiology, 1989
- Sulfated glycosaminoglycans modify growth factor‐induced neurite outgrowth in PC12 cellsJournal of Cellular Physiology, 1988
- Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitroBiochemical and Biophysical Research Communications, 1988
- Effect of fibroblast growth factor and lipoproteins on the proliferation of endothelial cells derived from bovine adrenal cortex, brain cortex, and corpus luteum capillariesJournal of Cellular Physiology, 1986
- Amino acid sequence of bovine brain derived class 1 heparin-binding growth factorBiochemistry, 1986
- Binding sites for glycosaminoglycans on developing sympathetic neuronesJournal of Neuroscience Research, 1986
- Primary structure of bovine brain acidic fibroblast growth factor (FGF)Biochemical and Biophysical Research Communications, 1985
- Lymphocytes express a diverse array of specific receptors for sulfated polysaccharidesCellular Immunology, 1985